A5073124750- Cardiac Valve Diseases and Treatments
- Cardiac Imaging and Diagnostics
- Infective Endocarditis Diagnosis and Management
- Mechanical Circulatory Support Devices
- Coronary Interventions and Diagnostics
- Heart Failure Treatment and Management
- Aortic Disease and Treatment Approaches
- Vascular Procedures and Complications
- Electrolyte and hormonal disorders
- Central Venous Catheters and Hemodialysis
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac Structural Anomalies and Repair
- Potassium and Related Disorders
- Acute Kidney Injury Research
- Dialysis and Renal Disease Management
- Cardiac Health and Mental Health
- Cardiovascular Effects of Exercise
- Takotsubo Cardiomyopathy and Associated Phenomena
- Nuclear Materials and Properties
- Radiation Shielding Materials Analysis
- Intensive Care Unit Cognitive Disorders
- Venous Thromboembolism Diagnosis and Management
- Trauma Management and Diagnosis
- Cardiac and Coronary Surgery Techniques
CentraCare Health System
2019-2025
St. Francis Hospital
2024
NewYork–Presbyterian Hospital
2024
Cardiovascular Research Foundation
2024
Columbia University Irving Medical Center
2024
Morristown Medical Center
2024
Cornell University
2024
St. Cloud Hospital
2017-2022
Scripps Clinic
2010
University of Minnesota
2005-2009
BackgroundFor patients with asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction, current guidelines recommend routine clinical surveillance every 6 to 12 months. Data from randomized trials examining whether early intervention transcatheter aortic-valve replacement (TAVR) will improve outcomes in these are lacking.MethodsAt 75 centers the United States Canada, we randomly assigned, a 1:1 ratio, undergo TAVR transfemoral placement of balloon-expandable valve...
Ultrafiltration enhances volume removal and weight reduction vs diuretics. However, their differential impact on total body sodium, potassium, magnesium has not been described. Fifteen patients with congestion despite diuretic therapy had urine electrolytes measured after a dose. was initiated ultrafiltrate were measured. The sodium diuretics (60+/-47 mmol/L) less than in the (134+/-8.0 (P=.000025). potassium level (41+/-23 greater (3.7+/-0.6 (P=.000017). (5.2+/-3.1 mg/dL) (2.9+/-0.7...
Background: The EARLY TAVR trial demonstrated that early transcatheter aortic valve replacement (TAVR) intervention was superior to clinical surveillance (CS) with delayed in patients asymptomatic, severe stenosis (AS). Cardiac biomarkers are associated maladaptive remodeling, symptom onset, and worse outcomes after TAVR. Whether elevated identify asymptomatic more likely benefit from is unknown. Methods: A core laboratory measured N-terminal pro-B-type natriuretic peptide (NT-proBNP) high...
Despite many reports of clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (HRPCI) with hemodynamic support, little is known about whether this approach improves left ventricular ejection fraction (LVEF). The purpose the present observational study was to examine, an ideal patient population Impella-supported HRPCI, there impact on function at midterm follow-up.
As transaxillary (TAx) access has become the most common alternative to transfemoral (TF) transcatheter aortic valve replacement (TAVR), there is increasing use of a percutaneous approach.This study sought determine whether are differences in outcomes using versus cutdown for TAx TAVR.Using data from STS/ACC TVT Registry, consecutive patients undergoing TAVR with balloon-expandable valves between July 2015 and December 2020 were included. Propensity score-based matching was performed...
Within the trans-subclavian approach, procedural techniques can vary widely, and reported access generally refers to an infraclavicular axillary approach. We describe report use of a novel supraclavicular true subclavian approach for transcatheter aortic valve replacement (TAVR) exclusively implantation Sapien 3 valves.We our first five consecutive patients undergoing TAVR with using standardized at single center. In-hospital 30-day complications were reported. The this resulted in...
Abstract Objective: An unmet need is represented in angioplasty catheters that permit the predilation stage of treating complex coronary anatomy oftentimes not amenable to conventional device therapies. Background: Lesion preparation with balloon prior stent placement remains most common method percutaneous revascularization. Methods: Clinical and angiographic outcomes were evaluated following a treatment strategy artery disease included low‐profile, 1.25‐mm catheter placement. The study...
Background The ACCESS Study is a prospective, multicenter registry to evaluate the efficacy and safety of trans-subclavian axillary transcatheter aortic valve replacement (TAx-TAVR) with latest-generation balloon-expandable (THV). secondary goal this study was determine whether type TAx access (left versus right, supraclavicular-subclavian infraclavicular-axillary, cutdown percutaneous) made difference in procedural 30-day outcomes.Methods 75 consecutive patients from March 2016 June 2018...
Residual pulmonary vascular obstruction (RPVO) following embolism (PE) is associated with residual dyspnea, recurrent venous thromboembolism, and chronic thromboembolic hypertension. Historically, acute PE treated anticoagulation alone results in high rates of significant RPVO. Contemporary treatment submassive often involves catheter-based interventions, including mechanical thrombectomy (MT), although their relation to RPVO not characterized. In this study, we aimed evaluate the rate ≥10%...